- - - Observed a protective effect against severe chemotherapy-induced anemia and thrombocytopenia across all dose levels - - - Management to host a conference call and webcast today at 8:30 a.m. EDT - - - WATERTOWN, Mass. , June 01, 2020 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN)
